|

Vitamin C (Laroscorbine) + Vitamin B1 (Bevitine) Clinical Trials

1 actively recruiting trial

Also known as: Laroscorbine + Bevitine

Pipeline

Phase 2: 1

Top Sponsors

  • Centre Hospitalier de Bethune1

Indications

  • Heart Disease1
  • Cardiac Arrest1

Other1 trial

Efficacy of Early Intravenous High-dose Vitamin C in Post-cardiac Arrest Shock.
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.